Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumors in Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05391867
What this trial is testing

Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sir Salimullah Medical College Mitford Hospital 70
Not applicableUnknownNCT04460157
What this trial is testing

Prediction of Liver-related Outcomes After HCV Cure

Who this might be right for
Hepatitis C, ChronicSustained Virological ResponseDirect-acting Antivirals+2 more
Hospital Universitario de Valme 1,035
Not applicableStudy completedNCT03782207
What this trial is testing

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

Who this might be right for
Urothelial CarcinomaNon-Small Cell Lung CancerSmall Cell Lung Cancer+1 more
Hoffmann-La Roche 2,756
Testing effectiveness (Phase 2)Looking for participantsNCT04982653
What this trial is testing

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

Who this might be right for
Liver and Intrahepatic Bile Duct NeoplasmMetastatic Malignant Neoplasm in the LiverPrimary Malignant Liver Neoplasm
M.D. Anderson Cancer Center 140
Early research (Phase 1)Study completedNCT00980239
What this trial is testing

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Who this might be right for
Liver CancerAdvanced Cancer
M.D. Anderson Cancer Center 115
Early research (Phase 1)Not Yet RecruitingNCT07430202
What this trial is testing

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Who this might be right for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)UnknownNCT02311205
What this trial is testing

Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)

Who this might be right for
Hepatocellular CarcinomaMetastasis
Asan Medical Center 55
Not applicableNot Yet RecruitingNCT06871930
What this trial is testing

Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease

Who this might be right for
Hepatocellular Carcinoma (HCC)
Assiut University 150
Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Not applicableStudy completedNCT01481805
What this trial is testing

Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Samsung Medical Center 100
Testing effectiveness (Phase 2)UnknownNCT05893056
What this trial is testing

Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)

Who this might be right for
Gastric Cancer Metastatic to Liver
Fudan University 25
Not applicableUnknownNCT04076631
What this trial is testing

Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Chen Xiaoping 1,000
Not applicableStudy completedNCT00499395
What this trial is testing

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4
Post-approval studies (Phase 4)Study completedNCT03007212
What this trial is testing

Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ain Shams University 30
Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Testing effectiveness (Phase 2)Ended earlyNCT01775267
What this trial is testing

ALLPS VERSUS PVO Randomized Controlled Trial

Who this might be right for
Liver Tumors Not Resectable in One Surgical Procedure
University of Zurich 7
Early research (Phase 1)Ended earlyNCT01744054
What this trial is testing

Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization

Who this might be right for
Liver Neoplasms
Washington University School of Medicine 57
Large-scale testing (Phase 3)Ended earlyNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Next Page